The negative outlook mainly reflects the industrywide challenges to maintain financial strength over the next one to two years. That's due to the risk that a prolonged low interest rate environment and high uncertainty over the coronavirus pandemic could result in capital market shocks in the coming quarters. Nonetheless, we expect Nan Shan Life to maintain its market position and competitive strength in local distribution channels. We continue to expect that, under Taiwan's regulatory framework for financial service sectors, Nan Shan Life will remain operationally independent from its main shareholders, Taiwan-based Ruentex and Pou Chen Corp. groups. We may lower the ratings if Nan Shan Life makes aggressive investment allocations, its asset liability mismatch deteriorates, or if the insurer reports